Global Adult Vaccine Market Report By Type (Preventive Vaccine And Therapeutic Vaccine), By Disease (Influenza, Meningococcal, Cervical Cancer, Zoster Shingles, Pneumococcal, Hepatitis, Measles, Mumps, Rubella And Varicella (MMRV), And Diphtheria, Tetanus, Pertussis (DTP)) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2017-2024
ID:VMR11210086
August 2018
Report Formats:

Rising prevalence of infectious diseases in the adult population is a prominent factor driving the market growth. Increasing investment in R&D by governmental bodies for the development of novel drugs and vaccine is further boosting the market growth. Also, rising awareness among the population regarding the advantages of vaccination is further pushing the market growth uphill. Favorable governmental support by arranging free campaign for vaccination is again fueling the market growth.

The latest report by Value Market Research expects the Global Adult Vaccine Market was valued at USD 15 billion in 2017 and is likely to reach USD 22.5 billion by 2024 with CAGR of 5%.
 
THERAPEUTIC VACCINES DOMINATED THE SEGMENT
In 2017, therapeutic vaccine led the segment and has accounted for X.X% of the total market share owing to its ability to induce an immune response and treat virus-infected cells is driving the market growth.
 
Influenza emerged as the leading disease
Influenza dominated the disease segment and has accounted for over 15% of the total market share.  Rising cases of acute respiratory infection, asthma, pneumonia, sinus problems, and other illness majorly caused by influenza are majorly driving the market growth.
 
NORTH AMERICA DOMINATED THE REGIONAL MARKET
Geographically, North America led the market and has accounted for X.X% of the total market share. The North American market is majorly driven owing to improved research infrastructure coupled with increased expenditure on healthcare. Rising initiates by the government for promoting vaccination is further fueling the regional market growth.
 
KEY PLAYERS OF THE MARKET
AstraZeneca Plc., Bharat Biotech, CSL Limited, Dynavax Technologies Corporation, GlaxoSmithKline, ImmunoBiology Ltd., Johnson & Johnson, Medimmune, Merck and Co., Novartis, Pfizer, Sanofi Pasteur and Serum Institute of India are the key players of the Adult Vaccine market.

As per this study the Global Adult Vaccine Market was valued at USD 15 BN (by revenue) in 2017 and is anticipated to reach USD 22.5 BN by 2024 with a CAGR of 5.0%.
 
Vaccine refers to a biological preparation that includes inactive antigen used to create an immune response. Adult vaccines impart immunity in the adult population from various fatal infectious diseases. Vaccination in adults varies depending upon the age, lifestyle, and health condition of the individual. Adult vaccines are used to provide immunity against diphtheria, influenza, hepatitis A & B, human papillomavirus (HPV), mumps, measles, rubella And varicella {MMRV}, and other infectious diseases.

Objectives of the Study:

  • Define and measure the global adult vaccine market
  • Revenue forecast of the global adult vaccine market and its various sub-segments with respect to main geographies
  • Analyze and identify among market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments
 
Market Dynamics
 
Rising prevalence of vaccine-preventable disease in adults leading to increased demand for novel vaccines is driving the market growth. Governmental initiates and free-campaign towards awareness of vaccines among the population is further fueling the market growth. Also, Governmental investment in R&D for the development of vaccines for fatal diseases is boosting the market growth. However, lack of skilled professional and side effects associated with the certain vaccine is expected to hinder the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of adult vaccine.
 
Market Segmentation
 
The broad adult vaccine market has been sub-grouped into type and disease. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Type
  • Preventive Vaccine
  • Therapeutic Vaccine
 
By Disease
  • Influenza
  • Meningococcal
  • Cervical Cancer
  • Zoster Shingles
  • Pneumococcal
  • Hepatitis, Measles, Mumps, Rubella And Varicella (MMRV)
  • Diphtheria, Tetanus, Pertussis (DTP)
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for adult vaccine in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Adult Vaccine Market By Revenue (USD MN)
 
North America Adult Vaccine Market By Revenue
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the adult vaccine market include AstraZeneca Plc., Bharat Biotech, CSL Limited, Dynavax Technologies Corporation, GlaxoSmithKline, ImmunoBiology Ltd., Johnson & Johnson, Medimmune, Merck and Co., Novartis, Pfizer, Sanofi Pasteur and Serum Institute of India. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.


METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand. 

1. INTRODUCTION

  • Introduction To Adult Vaccine
  • Report Description
    • Objectives Of The Study
    • Assumptions
  • Research Scope
  • Research Methodology
    • Data Source
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global Adult Vaccine Market: Snapshot
 
3. MARKET ANALYSIS
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
  • Value Chain Analysis
 
4. ADULT VACCINE MARKET ANALYSIS BY TYPE
  • Market In Preventive Vaccine
  • Market In Therapeutic Vaccine
 
5. ADULT VACCINE MARKET ANALYSIS BY DISEASE
  • Market In Influenza
  • Market In Meningococcal
  • Market In Cervical Cancer
  • Market In Zoster Shingles
  • Market In Pneumococcal,
  • Market In Hepatitis, Measles, Mumps, Rubella and Varicella (MMRV)
  • Market In Diphtheria, Tetanus, Pertussis (DTP)
 
6. ADULT VACCINE MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.) Market Estimates By Segments
    • Rest Of North America Market Estimates By Segments
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK) Market Estimates By Segments
    • Germany Market Estimates By Segments
    • France Market Estimates By Segments
    • Rest Of Europe Market Estimates By Segments
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China Market Estimates By Segments
    • Japan Market Estimates By Segments
    • India Market Estimates By Segments
    • Rest Of Asia Pacific Market Estimates By Segments  
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil Market Estimates By Segments
    • Rest Of Latin America Market Estimates By Segments
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East Market Estimates By Segments
    • Africa Market Estimates By Segments
 
7. COMPETITIVE LANDSCAPE OF THE ADULT VACCINE COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
8. COMPANY PROFILES OF THE ADULT VACCINE INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • AstraZeneca Plc.
  • Bharat Biotech
  • CSL Limited
  • Dynavax Technologies Corporation
  • GlaxoSmithKline
  • ImmunoBiology Ltd.
  • Johnson & Johnson
  • Medimmune
  • Merck and Co
  • Novartis
  • Pfizer
  • Sanofi Pasteur
  • Serum Institute of India
 
* Tentative TOC
 

LIST OF TABLES
 
Table 1.  Market Highlights Of Adult Vaccine
Table 2.  Global Adult Vaccine Market By Type
Table 3.  Global Adult Vaccine Market By Disease
Table 4.  Global Adult Vaccine Market By Geography
Table 5.  North America Adult Vaccine Market
Table 6.  Europe Adult Vaccine Market
Table 7.  Asia Pacific Adult Vaccine Market
Table 8.  Latin America Adult Vaccine Market
Table 9.  Middle East And Africa Adult Vaccine Market 
Table 10. Partnership/Collaboration/Agreements
Table 11. Mergers And Acquisitions
Table 12. New Product Development
Table 13. Other Developments
  
LIST OF FIGURES
 
Fig. 1.     Market Segmentation Of Adult Vaccine Market 
Fig. 2.     Top-Down Approach   
Fig. 3.     Bottom-Up Approach   
Fig. 4.     Market Highlights Of Adult Vaccine
Fig. 5.     Value Chain Analysis
Fig. 6.     Porter’s Five Forces Analysis
Fig. 7.     Global Adult Vaccine Market By Types
Fig. 8.     Global Adult Vaccine Market By Disease
Fig. 9.     Global Adult Vaccine Market By Geography
Fig. 10.   North America Adult Vaccine Market
Fig. 11.   Europe Adult Vaccine Market
Fig. 12.   Asia Pacific Adult Vaccine Market
Fig. 13.   Latin America Adult Vaccine Market
Fig. 14.   Middle East And Africa Adult Vaccine Market
Fig. 15.   Market Share Of Adult Vaccine Companies
Fig. 16.   Recent Developments In Adult Vaccine Industry
 
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.  

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials